Interference 102,413 Page 5
Pitha v. Muller
drug in an aqueous mixture of intrinsically amorphous
cyclodextrin derivatives or (2) a composition of matter made
by the method which contains amorphous complex of cyclodextrin
derivatives and a drug.
Glossary
The following abbreviations are used in this decision as
follows:
PR = Pitha record followed by the record
page number.
PX = Pitha exhibit followed by the exhibit
page number.
PB = Pitha brief followed by the page
number and line number.
PRB = Pitha reply brief followed by the page
number and line number.
BCD = beta-cyclodextrin
HPBCD = 2-hydroxypropyl-beta-cyclodextrin
PBCD = poly-beta-cyclodextrin
D. Pitha's Case
Pitha seeks to show prior conception and reduction to
practice before the critical date of December 21, 1983,
Muller’s earliest priority date (DE3346123.6). Pitha is
relying upon the experiments described in the laboratory
notebooks of Dr. Lajos Szente, Dr. Teresa Czajkowska and Dr.
Ciesielski to show a reduction to practice of an embodiment
within the scope of the count. The Pitha exhibits include,
inter alia, declarations and transcripts of oral testimony
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007